Coconuts Organic is a company that produces plant-based ice creams. Coconuts Organic asserts that it is one of only two mainstream organic plant-based ice cream brands in the UK. The company aims to tap into the fast-growing global trend of healthier eating and sustainable food. Coconuts Organic has won seven Great Taste Awards and became the fastest-growing 'Wellness Ice Cream' brand in the UK according to a May 2020 Nielsen report. Its products are stocked in major retail chains like M&S and Ocado. The company will use the investment to grow its sales and marketing team, increase its eCommerce business, scale its operations, and invest in marketing activity that will create consumer demand.
days to go:
Expired
investment:
£327,979
ByRuby is a food delivery company. It sources produce from local ethical suppliers, prepares meals in small batches using the raw produce, freezes the meal to preserve the taste, and delivers it nationwide. ByRuby argues that the UK ready meal sales market is worth £12 billion in 2020. The company witnessed sales up to 200% online in March 2020. ByRuby asserts that it uses only British free-range or organic meat & sustainably sourced fish from British waters. The company won the 2018 Women's Health Food Award. Its products are stocked in 26 retail stores. ByRuby has been mentioned by publications such as Daily Mail, Daily Telegraph, and Metro. It will use 50% of the investment for marketing, 26% to grow its kitchen team, 17% to upgrade its kitchen and 7% for new product development.
days to go:
Expired
investment:
£288,243
C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.
days to go:
Expired
investment:
£211,595
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.
days to go:
Expired
investment:
£270,543
Cornish Lithium (CL) is a mineral exploration company engaged in the discovery of lithium and other battery metals in Cornwall. It intends to create a 'Battery Metals Hub' in the UK through its efforts. CL has received funding to build the first European Union (EU) pilot lithium extraction plant powered by geothermal waters. It asserts that some of the world's highest grades of lithium are found in geothermal waters. The company has also secured UK Government funding for a new lithium extraction pilot plant in Cornwall. CL has drilled 41 shallow boreholes in a former china clay pit near St Austell, demonstrating the potential to extract lithium from granite. The company will use the investment to accelerate the company towards commercial production of lithium.
days to go:
Expired
investment:
£5,199,999
Living With is a health technology company offering a pocket-friendly and simple patient management application that allows medical professionals treat and track patients remotely. The app aims to revolutionise the way doctors and hospitals access digital tools to treat patients while collecting data for medical device and pharma companies. The company owns Squeezy (a popular paid medical app in the UK) and already has five products in 17 NHS Trusts. Living With also has a contract with one of the world’s greatest medical device companies. Living With will use the proceeds to give 5 data (drug/device) and 50 access customers (clinic/doctor), become HIPAA compliant for the US and to quicken sales and marketing.
days to go:
Expired
investment:
£200,000
MedicSpot is a healthcare company that is aiming to revolutionise healthcare delivery by combining the advantages of online and offline care. The company provides patients at designated hospitals with diagnostic tools like a stethoscope, oximeter, blood pressure monitor and thermometer which, in turn, is connected to the MedicSpot network. Onboard General Physicians (GPs) engage in live sessions with patients, guide them on how to use the tools, and perform a variety of diagnoses like listening to a patient’s heart and lungs, looking down their throat and into their ears, taking their blood pressure and oxygen readings, and measuring their body temperature. The company is also expanding into another subsidiary, Arc Health, which it claims will perform the aforementioned tasks with more efficiency and accuracy. The company will use the investment to increase the number of Medicspot clinics to 1,000, gain further NHS market share, launch a corporate business model and allow international pilots to take place.
days to go:
Expired
investment:
£1,048,396
gowithYamo aims to make art more accessible to everyone, from art newbies to experienced gallery-goers through its application. Users can collect Yamo points by checking-in to galleries and exchanging them for rewards such as art prints and exhibition tickets from the company's in-app store. gowithYamo provides support to galleries, museums and artists by exposing them to an active community of art lovers. The company also offers custom-built virtual exhibition spaces where artists can show and sell their work to a sizeable digital audience. gowithYamo has collaborated with art entities like Roy's Art Fair, The Other Art Fair, Harlesden High Street, and many others. It has a social media presence of 50,000+ followers. The company will use 30% of the investment to expand across different demographics, 25% to further finetune its virtual exhibition platform, 20% for marketing, and 25% to implement Artificial Intelligence (AI) in the gowithYamo app to help recommend exhibitions to its users.
days to go:
Expired
investment:
£161,105
Grocemania is an on-demand delivery platform, which allows customers to find and shop from local grocery stores and receive deliveries in minutes for only £2.50 at absolutely no cost to retailers. The company asserts that its team has been at the forefront of the pandemic delivering everyday essentials to thousands of people across London, Brighton, and Bristol in the UK. Grocemania has helped local retailers to generate £200,000 in sales through its platform since January 2020. It has allowed brands to subscribe and get detailed data analytics and sales insights about their products through its 'Data Reporting' module, and partnered with PepsiCo to maximize PepsiCo, Walkers, and Doritos sales during the UEFA Champions League Group Stage 2020. The company has featured in Timeout, The Grocer, Food Navigator, eMarketer, and UK Technews. It will use the investment to boost marketing and grow its monthly budget by 10 times, test its data module with current partnerships and create useful case-studies to secure more contracts, and invest more in local and product SEO.
days to go:
Expired
investment:
£173,781
MacRebur uses waste plastics destined for landfill or incineration and adding them into asphalt for road construction and surfacing to extend and enhance the bitumen (fossil fuel) binder. It argues that its carefully selected plastics, taken from the waste stream, are added into roads to improve strength and durability, whilst reducing the quantity of the oil-based bitumen used in a traditional road construction mix. MacRebur asserts that with each km of road laid using its MR products, the company sustainably uses up the equivalent weight of 740,541 one-time-use plastic bags. MacRebur has completed road tests in numerous countries including the UK and Europe, Turkey, Australia, and Japan to name a few. It has also signed agreements with India, the USA, Chile, Estonia, Kuwait, New Zealand, Switzerland, Bahrain, Spain, and Malaysia. The company will use the investment to build its manufacturing plants in five strategic locations across the world.
days to go:
Expired
investment:
£3,055,740
